EN
HI
Summary
As of 11 Sep, 2026, Bacil Pharma stock price is ₹19.38. During the trading session, the stock has moved between an intraday low of ₹18.83 and an intraday high of ₹19.38. Over the last 52 weeks, Bacil Pharma has traded between ₹10.65 and ₹61.80.
The stock has recorded a trading volume of 72,699 shares,. Its Average Traded Price (ATP) is ₹19.32, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 20 @ ₹19.38.
Bacil Pharma has an upper circuit limit of ₹19.38 and a lower circuit limit of ₹17.54. The total value traded stands at ₹14.05 L, and the delivery percentage for the day is 74.14%.
The stock is currently traded with a market lot size of 1. Bacil Pharma also offers a dividend yield of 0%.
Bacil Pharma Share Price Chart
Bacil Pharma Share Key Metrics
Volume
72699.00
Market Cap
11.41 CR
LTQ@LTP
20@19.38
ATP
19.32
Var Margin
100 %
Circuit Range
17.54-19.38
Delivery %
74.14 %
Value
14.05 L
ASM/GSM
No
Market Lot
1
Bacil Pharma Resistance and Support
Pivot 17.95
Resistance
First Resistance
19.08
Second Resistance
19.71
Third Resistance
20.84
Support
First Support
17.32
Second Support
16.19
Third Support
15.56
Bacil Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 19.24 | 19.38 | 5.04% | 19.38 | 18.83 |
| Thu Sep 10 2026 | 18 | 18.45 | 4.24% | 18.57 | 16.81 |
| Wed Sep 09 2026 | 17.7 | 17.7 | 4.98% | 17.7 | 17 |
Bacil Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-29 | A.G.M. |
| 2026-08-25 | Others |
| 2026-08-12 | Quarterly Results |
| 2026-07-09 | Others |
| 2026-06-26 | Fund Raising & Others |
| 2026-05-22 | Audited Results |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-09-05 | Others |
| 2025-08-25 | Others |
| 2025-08-12 | Quarterly Results |
| 2025-07-16 | Others |
| 2025-05-26 | Audited Results |
| 2025-01-21 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
| 2024-10-15 | Others |
| 2024-09-27 | Increase in Authorised Capital |
| 2024-08-14 | Quarterly Results |
Bacil Pharma News
Bacil Pharma Ltd - 524516 - Board Meeting Intimation for Bacil Pharma Limited ("The Company") Will Be Held On 29Th August, 2026
Bacil Pharma board is scheduled to meet on August 29, 2026. Key agenda includes discussion and approval of the Director Report for FY2025-26 and fixing the date, place, and timing for the 39th Annual General Meeting.
Aug 26 2026 18:42:42
Bacil Pharma Ltd - 524516 - Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th August, 2026
Bacil Pharma's board approved the appointment of Mr. Mahesh Singh as Non-Executive Independent Director and Mr. Anil Shiv Charan Singh as Non-Executive Director. These appointments aim to strengthen the Board with expertise in financial matters and commodity trading, respectively.
Aug 25 2026 16:50:00
Read More
Bacil Pharma Management
| Name | Position |
|---|---|
| Dinesh Chander Notiyal | Non Executive Independent Director |
| Avani Savjibhai Godhaniya | Non Executive Independent Director |
Bacil Pharma Similar Stocks
Chennai Meenakshi Multispeciality Hospital Ltd.
37.94
-0.31 (0.81%)
Deccan Health Care Ltd.
12.50
0.27 (2.21%)
Tejnaksh Healthcare Ltd.
13.44
0.19 (1.43%)
Gujarat Inject (Kerala) Ltd.
10.10
-0.15 (1.46%)
Ishita Drugs & Industries Ltd.
73.75
-0.25 (0.34%)
Emmessar Biotech & Nutrition Ltd.
23.58
-0.91 (3.72%)
Beryl Drugs Ltd.
23.99
-0.13 (0.54%)
Bacil Pharma FAQs
The Buying Price of Bacil Pharma share is 19.38 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bacil Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bacil Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bacil Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bacil Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Bacil Pharma’s valuation compare Sector P/E, P/B which are 41.56 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bacil Pharma is 11.41 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bacil Pharma share price is 61.80 & 10.65. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bacil Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in BACPHAR
